Submissions by aaavl2821

A guided financial analysis of an $8.7B gene therapy startup

How do you predict whether a biotech company will pass phase 2 or 3 trials?

UBiome has placed its founders on leave following FBI raid

The case for young biotech founders

A new kind of bio startup needs a new kind of founder

Why don't biotech VCs fund young CEOs?

Most big biotech companies are started by inexperienced CEOs

Don’t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns

Venture returns from recent biopharma IPOs

Valuations of Biotech Startups from Series A to IPO

Recent IPOs illustrate the changing “physics” of biotech VC

Cats and the Future of Machine Learning in Drug Discovery

Gene therapy for SMA could be cost-effective at price of $1-1.5M [pdf]

After another anti-amyloid failure, drugmakers throw more good money after bad

Are startups 10x better at R&D than big pharma?

Show HN: Find potential investors for biotherapeutics startups